News
-
-
-
COMMUNIQUÉ DE PRESSE
PVA TePla: Order intake up significantly in the third quarter, revenue and earnings impacted by project delays
PVA TePla AG reports a significant increase in order intake, while revenue and earnings are impacted by project delays. Guidance for full year 2025 adjusted. Integration and capacity expansion strengthen technological basis and performance -
-
COMMUNIQUÉ DE PRESSE
Zehnder Group Capital Markets Day Promising future prospects for Zehnder's ventilation business
Zehnder Group AG presents future prospects for its ventilation business at Capital Markets Day, focusing on innovative solutions for indoor climate. Strategic growth plans for Europe and North America highlighted -
COMMUNIQUÉ DE PRESSE
Advancing Innovation with Openness -- Huawei holds the 6th Innovation and IP Forum
Huawei holds its 6th Innovation and IP Forum, emphasizing the importance of openness and IP protection in driving innovation and social progress. Key focus on patent licensing revenue and collaborations for industry growth -
COMMUNIQUÉ DE PRESSE
DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux arachides
DBV Technologies annonce la fin de la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants allergiques aux arachides, se rapprochant ainsi de la publication des résultats préliminaires -
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies completes last patient visit in Phase 3 VITESSE Clinical Trial of VIASKIN Peanut Patch for peanut allergic children aged 4-7 years; on track for Q4 data announcement -
-
